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Background: In percutaneous coronary intervention (PCI), patients with renal dysfunction has had high rate of restenosis. Our aim was to compare 
the clinical outcomes of CKD patients every kind of drug-eluting stents (DES) after PCI.
Methods: 738 consecutive patients (1224 lesions) on CKD (eGFR<60[ml/min 1.73m2]: calculated by the simplfied Modification of Diet in Renal 
Disease equation) were treated with sirolimus-eluting stent (SES, S group: 688), paclitaxel-eluting stent (PES, P group: 471) or Zotarolimus-eluting 
stent(ZES, Z group: 65 lesions) implantation between April 2007 and December 2009, and were follow up to 8 months. The primary endpoints were 
angiographic outcomes and MACE (death, AMI, CABG, target lesion revascularization: TLR).
Results: No significant difference was detected in the baseline demographic, angiographic, and lesion characteristics. In 8 months follow-up, the 
mean values of late lumen loss were significantly lower in the S group(0.3±0.8mm) than other group(P group: 0.5±0.8mm, Z group: 0.6±0.9mm; 
p<0.01). However, no significant difference was detected in the rates of binary restenosis (%DS>50%)(S group:7.6, P group: 9.8, Z group: 9.2%; 
p=0.41), TLR(S group:3.8, P group: 5.7, Z group: 3.1%; p=0.25), and MACE(S group: 5.6, P group: 6.7 , Z group: 3.1%; p=0.38). There was no 
correlative relationship between eGFR and diameter restenosis (see figure).
Conclusions: For patients of CKD, clinical and angiographic outcomes were similar in the SES, PES and ZES implantation.
